Skip to Content

The Italian Biotech Start-up founded by San Raffaele Hospital, Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner, raised a Euro 10 million ($11 million) Series A round with the support of Banca Esperia.

Sep 11, 2014

Milan, March 5th, 2015. After a few weeks from the first closing, GENENTA SCIENCE banked an overall Euro 10.0 million (USD 11.0 million) Series A round, the company target.

  • The funding campaign was supported by Banca Esperia, the Private Bank of Mediobanca (MB:IM) and Mediolanum (MED:IM).
  • The private offering was oversubscribed.
  • The Series A round was led by private investors: entrepreneurs, managers, HNWI, family offices.
  • The entrance of new shareholders allows GENENETA SCIENCE to complete pre-clinical studies and to advance in the preparation of the clinical phase for its therapeutic protocols to treat tumors.